Congress Park Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.08M Sell
3,524
-83
-2% -$97.9K 1.07% 28
2026
Q2
$4.33M Sell
3,607
-2
-0.1% -$2.04K 1.17% 26
2026
Q1
$3.32M Sell
3,609
-49
-1% -$49.7K 1.02% 27
2025
Q4
$3.93M Sell
3,658
-55
-1% -$52.6K 1.17% 27
2025
Q3
$2.83M Buy
3,713
+386
+12% +$287K 0.88% 32
2025
Q2
$2.59M Buy
3,327
+150
+5% +$117K 0.85% 32
2025
Q1
$2.62M Sell
3,177
-7
-0.2% -$5.82K 0.99% 24
2024
Q4
$2.46M Sell
3,184
-24
-0.7% -$19.9K 0.89% 33
2024
Q3
$2.84M Sell
3,208
-22
-0.7% -$19.8K 1.05% 29
2024
Q2
$2.92M Sell
3,230
-22
-0.7% -$17.6K 1.17% 26
2024
Q1
$2.53M Sell
3,252
-181
-5% -$129K 1.12% 29
2023
Q4
$2M Sell
3,433
-229
-6% -$134K 0.98% 31
2023
Q3
$1.97M Buy
3,662
+606
+20% +$312K 1.02% 29
2023
Q2
$1.43M Buy
3,056
+1,115
+57% +$468K 0.72% 37
2023
Q1
$667K Hold
1,941
– – 0.35% 66
2022
Q4
$710K Buy
+1,941
New +$688K 0.42% 61

Other funds holding LLY

Congress Park Capital's LLY Position: Q3 2026 in Review

Congress Park Capital reduced its Eli Lilly (LLY) stake by 2.3% in Q3 2026, selling an estimated $97.9K and leaving 3,524 shares worth $4.08M. The position accounts for 1.07% of the portfolio, ranked #28.

Congress Park Capital first reported a position in LLY in Q4 2022 and has held it in 16 quarters since. The position peaked at $4.33M in Q2 2026. 3,287 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Congress Park Capital held 3,524 shares of Eli Lilly worth $4.08M as of Q3 2026.
  • Congress Park Capital sold 83 Eli Lilly shares in Q3 2026, an estimated $97.9K.
  • Eli Lilly made up 1.07% of Congress Park Capital's portfolio in Q3 2026, its #28 holding.
  • Congress Park Capital first reported a position in Eli Lilly in Q4 2022 and has held it in 16 quarters since.
  • Congress Park Capital's Eli Lilly position peaked at $4.33M in Q2 2026.
  • 3,287 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Congress Park Capital's 13F filing for Q3 2026, filed 13 Oct 2026.